Investing Profile

Jayson Punwani

InvestorVC
Managing Director at Abingworth
abingworth.com/team/jayson-pu...Menlo Park, California
Photo of Jayson Punwani, Managing Director at Abingworth

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Hotmail Network
4899 CONNECTIONS
UNC Kenan-Flagler Business School Network
22 CONNECTIONS
University of Utah Network
17 CONNECTIONS
Abingworth Network
13 CONNECTIONS
Abingworth Network
13 CONNECTIONS
cb
Abingworth Managing Director
$15.0M - $30.0M
$22.5M
4
$465M
CompanyStageDateRound SizeTotal Raised
Addition Therapeutics
Series ADec 2025$100M
$100M
Co-investors: Jennifer Lee (Pivotal bioVenture Partners), Peter Bisgaard (Pivotal bioVenture Partners)
Xilio Therapeutics
Series CFeb 2021$95M
Series BMar 2020$100M
$330M
Co-investors: Andrew Hack (Bain Capital Ventures), Peter Dudek (M Ventures (Merck)), Mike Ross (SV Health Investors), Nancy Hong (San Diego Symphony), Jack Kenney (SV Health Investors)
StrideBio
Series AJun 2018$16M
$98M
Co-investors: Karen Hong (De Novo Ventures), Shaan C. Gandhi (Longwood Fund)
Postdoctoral Research Associate University of North Carolina at Chapel HillPresent
Technology Development @ OTD University of North Carolina at Chapel HillPresent
Director TeramerauskaPresent
Principal Pappas CapitalPresent
Managing Director AbingworthPresent
Partner Takeda Ventures, Inc.Present
Co-founder Coho TherapeuticsPresent
Interim CEO HotmailPresent
Partner AbingworthPresent
UNC Kenan-Flagler Business School MBA Finance and Entrepreneurship
The College of New Jersey BS Biology, Chemistry Minor
University of Utah PhD Biology